Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5857 posts found.

shutterstock_273326141

South Korea secures enough COVID-19 vaccine doses for 44 million citizens

December 8, 2020 Manufacturing and Production, Sales and Marketing COVID-19, Vaccine, south korea

The South Korean Government has announced plans to secure enough COVID-19 vaccine doses to inoculate 44 million of its citizens, …
News
takeda_usa_pharmaceuticals_u

China approves Takeda’s Takhzyro to prevent hereditary angioedema attacks in patients over 12

December 8, 2020 Manufacturing and Production, Sales and Marketing China, Takeda

China’s National Medical Products Administration (NMPA) has given approval in the country for Takeda’s Takhzyro (lanadelumab), in a subcutaneous injection …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Dupixent, EMA, UK, Vaccine, top ten

As the year winds to a close, excitement is rising around the efficacy and availability of COVID-19 vaccines around the …
News
shutterstock_103378880

IBM uncovers “precision phishing campaign” targeting global COVID-19 vaccine cold chain supply

December 4, 2020 Manufacturing and Production, Medical Communications, Research and Development COVID-19, Vaccine, ibm

US tech firm IBM has reported that it has identified attempts by unknown parties to hack and disrupt elements of …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 2, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Image credit: CDC, Top 5, Vaccine

EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe – Published on 01/12/20
News
pharmafile_autumn_2020_front_cover

The Autumn 2020 edition of Pharmafile is available to read for free online now!

December 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing infectious diseases, pharmafile, rare disease, respiratory

The Autumn 2020 edition of Pharmafile is available to read for free online now! 2020 has seen almost unprecedented disruption …
News
shutterstock_273326141

Eisai and Wren Therapeutics join forces to tackle neurodegenerative synucleinopathies

December 1, 2020 Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Wren Therapeutics

Eisai has forged an exclusive research partnership with Wren Therapeutics to develop new approaches in tackling neurodegenerative diseases known as …
News
1

EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe

December 1, 2020 Manufacturing and Production, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

Pfizer and BioNTech have officially submitted their application to secure conditional marketing authorisation to the European Medicines Agency (EMA) for …
News
shutterstock_138095450

Grünenthal buys European rights to AstraZeneca’s Crestor for a potential $350m

December 1, 2020 Manufacturing and Production, Sales and Marketing AstraZeneca, Crestor, Grunenthal

Grünenthal has picked up AstraZeneca’s statin therapy Crestor (rosuvastatin), currently approved in dyslipidaemia and hypercholesterolaemia treatment, in a deal worth …
News
avantor

Optimise your clinical trials with Avantor Clinical Services

December 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020 Campaign, Avantor, clinical trials, expertise

Serious diseases like COVID-19 put increasing pressure on researchers to find breakthrough treatments faster. Along with accelerated timelines, biopharma and …
News
astrazeneca_sign_sky

Philippines poised to secure two million AstraZeneca COVID-19 vaccine doses

November 26, 2020 Manufacturing and Production AstraZeneca, COVID-19, Vaccine

The Philippines is set to imminently seal a deal with AstraZeneca for two million doses of AstraZeneca’s COVID-19 vaccine, it …
News
lilly_building_with_american_flag_web

Canada secures 26,000 doses of Lilly therapy to treat COVID-19 in $32.5m deal

November 25, 2020 Manufacturing and Production, Research and Development COVID-19, Canada

The Canadian Government has partnered up with Eli Lilly to secure 26,000 doses of the company’s monoclonal antibody therapy bamlanivimab …
News
pharmafocus_december_2020_cover

The December 2020 issue of Pharmafocus is available to read free online now!

November 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing

The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …
News
fdaoutsideweb

FDA expands approval of Genentech’s Xofluza for post-exposure prevention of influenza

November 24, 2020 Manufacturing and Production, Sales and Marketing FDA, Xofluza, influenza

Genentech has secured FDA approval for Xofluza (baloxavir marboxil) for the post-exposure prevention of influenza in patients at least 12 …
News
british_houses_of_parliament

UK deaths currently a fifth higher than normal levels

November 24, 2020 Manufacturing and Production

Deaths across the UK are a fifth higher than normal, according to new government data.  Numbers released from UK Government …
News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026